202 related articles for article (PubMed ID: 26119013)
1. Does rumination mediate the relationship between mindfulness and depressive relapse?
Kearns NP; Shawyer F; Brooker JE; Graham AL; Enticott JC; Martin PR; Meadows GN
Psychol Psychother; 2016 Mar; 89(1):33-49. PubMed ID: 26119013
[TBL] [Abstract][Full Text] [Related]
2. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up.
Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z
Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
[TBL] [Abstract][Full Text] [Related]
4. Rumination as a predictor of relapse in mindfulness-based cognitive therapy for depression.
Michalak J; Hölz A; Teismann T
Psychol Psychother; 2011 Jun; 84(2):230-6. PubMed ID: 22903859
[TBL] [Abstract][Full Text] [Related]
5. Web-based Mindfulness-based Cognitive Therapy for reducing residual depressive symptoms: An open trial and quasi-experimental comparison to propensity score matched controls.
Dimidjian S; Beck A; Felder JN; Boggs JM; Gallop R; Segal ZV
Behav Res Ther; 2014 Dec; 63():83-9. PubMed ID: 25461782
[TBL] [Abstract][Full Text] [Related]
6. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
[TBL] [Abstract][Full Text] [Related]
7. Mindfulness predicts relapse/recurrence in major depressive disorder after mindfulness-based cognitive therapy.
Michalak J; Heidenreich T; Meibert P; Schulte D
J Nerv Ment Dis; 2008 Aug; 196(8):630-3. PubMed ID: 18974675
[TBL] [Abstract][Full Text] [Related]
8. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
[TBL] [Abstract][Full Text] [Related]
9. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
Shallcross AJ; Gross JJ; Visvanathan PD; Kumar N; Palfrey A; Ford BQ; Dimidjian S; Shirk S; Holm-Denoma J; Goode KM; Cox E; Chaplin W; Mauss IB
J Consult Clin Psychol; 2015 Oct; 83(5):964-75. PubMed ID: 26371618
[TBL] [Abstract][Full Text] [Related]
10. LONG-TERM OUTCOME OF MINDFULNESS-BASED COGNITIVE THERAPY IN RECURRENTLY DEPRESSED PATIENTS WITH AND WITHOUT A DEPRESSIVE EPISODE AT BASELINE.
van Aalderen JR; Donders AR; Peffer K; Speckens AE
Depress Anxiety; 2015 Aug; 32(8):563-9. PubMed ID: 25869231
[TBL] [Abstract][Full Text] [Related]
11. Mindfulness-based cognitive therapy for residual depressive symptoms.
Kingston T; Dooley B; Bates A; Lawlor E; Malone K
Psychol Psychother; 2007 Jun; 80(Pt 2):193-203. PubMed ID: 17535594
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
[TBL] [Abstract][Full Text] [Related]
13. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
[TBL] [Abstract][Full Text] [Related]
14. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
[TBL] [Abstract][Full Text] [Related]
15. Cognitive reactivity as outcome and working mechanism of mindfulness-based cognitive therapy for recurrently depressed patients in remission.
Cladder-Micus MB; van Aalderen J; Donders ART; Spijker J; Vrijsen JN; Speckens AEM
Cogn Emot; 2018 Mar; 32(2):371-378. PubMed ID: 28278742
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder.
van der Velden AM; Kuyken W; Wattar U; Crane C; Pallesen KJ; Dahlgaard J; Fjorback LO; Piet J
Clin Psychol Rev; 2015 Apr; 37():26-39. PubMed ID: 25748559
[TBL] [Abstract][Full Text] [Related]
17. Practice of therapy acquired regulatory skills and depressive relapse/recurrence prophylaxis following cognitive therapy or mindfulness based cognitive therapy.
Segal ZV; Anderson AK; Gulamani T; Dinh Williams LA; Desormeau P; Ferguson A; Walsh K; Farb NAS
J Consult Clin Psychol; 2019 Feb; 87(2):161-170. PubMed ID: 30431297
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial.
van Aalderen JR; Donders AR; Giommi F; Spinhoven P; Barendregt HP; Speckens AE
Psychol Med; 2012 May; 42(5):989-1001. PubMed ID: 22017808
[TBL] [Abstract][Full Text] [Related]
19. Mindfulness-based cognitive therapy for recurrent major depression: A 'best buy' for health care?
Shawyer F; Enticott JC; Özmen M; Inder B; Meadows GN
Aust N Z J Psychiatry; 2016 Oct; 50(10):1001-13. PubMed ID: 27095791
[TBL] [Abstract][Full Text] [Related]
20. The effects of mindfulness-based cognitive therapy on risk and protective factors of depressive relapse - a randomized wait-list controlled trial.
Schanche E; Vøllestad J; Visted E; Svendsen JL; Osnes B; Binder PE; Franer P; Sørensen L
BMC Psychol; 2020 Jun; 8(1):57. PubMed ID: 32503649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
